Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Exp Allergy ; 47(12): 1599-1608, 2017 Dec.
Article in English | MEDLINE | ID: mdl-28756630

ABSTRACT

BACKGROUND: There is now increasing evidence that asthma and atopy originate in part in utero, with disease risk being associated with the altered epigenetic regulation of genes. OBJECTIVE AND METHODS: To determine the relationship between variations in DNA methylation at birth and the development of allergic disease, we examined the methylation status of CpG loci within the promoter regions of Th1/2 lineage commitment genes (GATA3, IL-4, IL-4R, STAT4 and TBET) in umbilical cord DNA at birth in a cohort of infants from the Southampton Women's Survey (n = 696) who were later assessed for asthma, atopic eczema and atopy. RESULTS: We found that higher methylation of GATA3 CpGs -2211/-2209 at birth was associated with a reduced risk of asthma at ages 3 (median ratio [median methylation in asthma group/median methylation in non-asthma group] = 0.74, P = .006) and 6-7 (median ratio 0.90, P = .048) years. Furthermore, we demonstrated that the GATA3 CpG loci associated with later risk of asthma lie within a NF-κB binding site and that methylation here blocks transcription factor binding to the GATA3 promoter in the human Jurkat T-cell line. Associations between umbilical cord methylation of CpG loci within IL-4R with atopic eczema at 12 months (median ratio 1.02, P = .028), and TBET with atopy (median ratio 0.98, P = .017) at 6-7 years of age were also observed. CONCLUSIONS AND CLINICAL RELEVANCE: Our findings provide further evidence of a developmental contribution to the risk of later allergic disorders and suggest that involvement of epigenetic mechanisms in childhood asthma is already demonstrable at birth.


Subject(s)
DNA Methylation , Genetic Predisposition to Disease , Hypersensitivity/etiology , Th2 Cells/immunology , Th2 Cells/metabolism , Age Factors , Age of Onset , Binding Sites , Case-Control Studies , Cell Lineage/genetics , Child , Child, Preschool , CpG Islands , Dermatitis, Atopic/epidemiology , Dermatitis, Atopic/etiology , Dermatitis, Atopic/metabolism , GATA3 Transcription Factor/metabolism , Humans , Hypersensitivity/epidemiology , Hypersensitivity/metabolism , Promoter Regions, Genetic , Protein Binding , Umbilical Cord/metabolism
2.
Clin Exp Allergy ; 47(6): 760-769, 2017 Jun.
Article in English | MEDLINE | ID: mdl-28218994

ABSTRACT

BACKGROUND: Perinatal maternal stress and low mood have been linked to offspring atopic eczema. OBJECTIVES: To examine the relation of maternal stress/mood with atopic eczema in the offspring, focusing particularly on stress/psychological distress preconception. METHODS: At recruitment in the UK Southampton Women's Survey, preconception maternal reports of perceived stress in daily living and the effect of stress on health were recorded; in a subsample, psychological distress was assessed (12-item General Health Questionnaire). Infants were followed up at ages 6 (n = 2956) and 12 (n = 2872) months and atopic eczema ascertained (based on UK Working Party Criteria for the Definition of Atopic Dermatitis). At 6 months post-partum, mothers were asked if they had experienced symptoms of low mood since childbirth and completed the Edinburgh Postnatal Depression Scale. RESULTS: Preconception perceived stress affecting health [OR 1.21 (95% CI 1.08-1.35), P = 0.001] and stress in daily living [OR 1.16 (1.03-1.30), P = 0.014] were associated with an increased risk of offspring atopic eczema at age 12 months but not at 6 months, robust to adjustment for potentially confounding variables. Findings were similar for maternal psychological distress preconception. Low maternal mood between delivery and 6 months post-partum was associated with an increased risk of infantile atopic eczema at age 12 months, but no significant association between post-natal mood and atopic eczema was seen after taking account of preconception stress. CONCLUSION AND CLINICAL RELEVANCE: Our data provide novel evidence linking maternal stress at preconception to atopic eczema risk, supporting a developmental contribution to the aetiology of atopic eczema and pointing to potentially modifiable influences.


Subject(s)
Dermatitis, Atopic/epidemiology , Mothers/psychology , Prenatal Exposure Delayed Effects , Stress, Psychological/complications , Adult , Child , Child, Preschool , Female , Humans , Infant , Infant, Newborn , Pregnancy , Risk Factors , Surveys and Questionnaires
5.
Clin Exp Allergy ; 46(10): 1337-43, 2016 10.
Article in English | MEDLINE | ID: mdl-27517618

ABSTRACT

BACKGROUND: Evidence that atopic eczema partly originates in utero is increasing, with some studies linking the risk of developing the condition with aspects of maternal diet during pregnancy. Nicotinamide, a naturally occurring nutrient that is maintained through the dietary intakes of vitamin B3 and tryptophan, has been used in the treatment of some skin conditions including atopic eczema. OBJECTIVE: To examine the relation of maternal serum concentrations of nicotinamide and related tryptophan metabolites to the risk of atopic eczema in the offspring. METHODS: Within the UK Southampton Women Survey, infantile atopic eczema at ages 6 and 12 months was ascertained (modified UK Working Party Criteria for the Definition of Atopic Dermatitis). Maternal serum levels of kynurenine, kynurenic acid, anthranilic acid, tryptophan, nicotinamide and N1-methylnicotinamide were measured in late pregnancy by mass spectrometry (n = 497) and related to the odds ratio of infantile atopic eczema. RESULTS: Maternal nicotinamide and related metabolite concentrations were not associated with offspring atopic eczema at age 6 months. Higher concentrations of nicotinamide and anthranilic acid were, however, associated with a lower risk of eczema at age 12 months (odds ratios 0.69, 95% CI 0.53-0.91/SD change, P = 0.007 and 0.63, 0.48-0.83, P = 0.001, respectively). The associations were robust to adjustment for potentially confounding variables. CONCLUSION AND CLINICAL RELEVANCE: This is the first study linking maternal serum concentrations of nicotinamide and related metabolites to the risk of atopic eczema in the offspring. The findings point to potentially modifiable maternal influences on this complex and highly prevalent condition.


Subject(s)
Dermatitis, Atopic/epidemiology , Dermatitis, Atopic/etiology , Maternal Exposure , Niacinamide/blood , Prenatal Exposure Delayed Effects , Adult , Age Factors , Biomarkers , Comorbidity , Female , Humans , Infant , Kynurenine/metabolism , Male , Maternal Exposure/adverse effects , Metabolic Networks and Pathways , Niacinamide/analogs & derivatives , Odds Ratio , Pregnancy , Prognosis , Risk , Risk Factors
6.
Dermatol Online J ; 22(11)2016 Nov 15.
Article in English | MEDLINE | ID: mdl-28329579

ABSTRACT

Habit tic nail deformity is a nail dystrophy resulting from habitual, repetitive trauma to the nail. It is usually acquired in adulthood, however, we report a case of habit tic nail deformity in an 8 year old boy. The diagnosis was made clinically with further history revealing that the boy repeatedly rubbed his thumbnails and pushed the cuticles. Emollient cream (Balneum®) was recommended twice daily and both the patient and his mother were educated on the behavioral nature of this condition. There was marked improvement at 6 months of treatment and further improvement at 12 months.We note that habit tic nail deformity is not exclusive to adults. Diagnosis can be made clinically. History and physical examination provide valuable clues and psychosocial links must be explored and addressed. Management is challenging and compliance with treatment is variable. Patient education, barrier methods, and behavioral therapy can be helpful in preventing further trauma to the nails.


Subject(s)
Habits , Nail Diseases/diagnosis , Nails/injuries , Tics/complications , Child , Humans , Male , Nail Diseases/etiology
7.
Dermatol Online J ; 21(5)2015 May 18.
Article in English | MEDLINE | ID: mdl-26295863

ABSTRACT

Topical calcineurin inhibitors have been used outside their approved indications for a number of conditions, including topical steroid-induced rosacea. However, tacrolimus ointment itself has been reported to trigger rosacea in a small number of cases. We report a case of a rosacea-like eruption in a 39-year-old woman occurring after the use of pimecrolimus cream for 12 months for atopic dermatitis. Withdrawal of pimecrolimus combined with treatment with oral lymecycline, topical metronidazole, and an emollient resulted in resolution of the eruption. There have been 5 previously reported cases of a topical pimecrolimus-induced rosacea-like eruption suggesting that this rare side-effect may be a class effect of all topical calcineurin inhibitors. Dermatologists prescribing these drugs should be aware of this uncommon complication and may wish to warn patients of its occurrence as a potential side-effect when using topical calcineurin inhibitors in facial skin in adults.


Subject(s)
Drug Eruptions/etiology , Facial Dermatoses/chemically induced , Rosacea/chemically induced , Tacrolimus/analogs & derivatives , Administration, Cutaneous , Adult , Dermatologic Agents/administration & dosage , Dermatologic Agents/adverse effects , Drug Eruptions/diagnosis , Facial Dermatoses/diagnosis , Female , Humans , Peptidylprolyl Isomerase/antagonists & inhibitors , Rosacea/diagnosis , Tacrolimus/administration & dosage , Tacrolimus/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL
...